C2987574_NCI_NCI-GLOSS | Knowledge4COVID-19

Property	Value
?:definition	A substance being studied in the treatment of cancer. CT-322 may prevent the growth of new blood vessels that tumors need to grow and may kill cancer cells. It is a type of vascular endothelial growth factor receptor-2 (VEGFR-2) inhibitor and a type of antiangiogenesis agent.
?:hasCUIAnnotation	<https://research.tib.eu/covid-19/entity/C2987574>
?:hasGeneratedBy	<https://research.tib.eu/covid-19/SourceName/NCI_NCI-GLOSS>
?:type	<https://research.tib.eu/covid-19/vocab/AnnotationDefinition>

Metadata

Anon_0

<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>

<http://purl.org/net/provenance/ns#DataItem>

<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>

<http://www.w3.org/2004/03/trix/rdfg-1/Graph>

<http://xmlns.com/foaf/0.1/primaryTopic>

<https://research.tib.eu/covid-19/entity/C2987574_NCI_NCI-GLOSS>

<http://xmlns.com/foaf/0.1/topic>

Anon_0

<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes>

<https://research.tib.eu/covid-19/data/entity/C2987574_NCI_NCI-GLOSS>

<http://purl.org/net/provenance/ns#createdBy>

Anon_1 (more)

expand all